Abstract
Aptamers are oligonucleotides obtained by a combinatorial method from randomly synthesized libraries. They usually exhibit strong affinity and high specificity of interaction with a predetermined target. They actually rival antibodies and are of interest for multiple purposes, notably for diagnostic. As aptamers can be easily immobilized on a number of surfaces, they can be used for detecting the presence of viral constituents, RNA or proteins. The detection can be carried out in a number of different formats (fluorescence, SPR, etc.). We raised aptamers against RNA motifs of the human immunodeficiency virus or of the hepatitis C virus. Such aptamers display a very high specificity of recognition, surpassing that of complementary oligonucleotides as they recognize the 3D shape and not only the primary sequence. We also raised aptamers against the M1 protein of the influenza virus allowing its detection. We took advantage of fluorescence transfer for monitoring interactions between aptamers and their cognate ligand immobilized on particles. This strategy could be used either for screening libraries or for evaluating the presence of an analyte.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aldaz-Carroll L, Tallet B, Dausse E et al (2002) Apical loop-internal loop interactions: a new RNA-RNA recognition motif identified through in vitro selection against RNA hairpins of the hepatitis C virus mRNA. Biochemistry 41:5883–5893
Andréola ML, Calmels C, Michel J et al (2000) Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides. Eur J Biochem 267:5032–5040
Andréola ML, Pileur F, Calmels C et al (2001) DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry 40:10087–10094
Arnold S, Pampalakis G, Kantiotou K et al (2012) One round of SELEX for the generation of DNA aptamers directed against KLK6. Biol Chem 393:343–353
Baudin F, Bach C, Cusack S et al (1994) Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J 13:3158–3165
Beaurain F, Di Primo C, Toulmé JJ et al (2003) Molecular dynamics reveals the stabilizing role of loop closing residues in kissing interactions: comparison between TAR-TAR* and TAR-aptamer. Nucleic Acids Res 31:4275–4284
Bellecave P, Andréola ML, Ventura M et al (2003) Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro. Oligonucleotides 13:455–463
Berezhnoy A, Stewart CA, McNamara JO et al (2012) Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther 20:1242–1250
Berezovski M, Musheev M, Drabovich A et al (2006) Non-SELEX selection of aptamers. J Am Chem Soc 128:1410–1411
Berkhout B (2000) Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome. Adv Pharmacol 48:29–73
Binning JM, Leung DW (2012) Aptamers in virology: recent advances and challenges. Front Microbiol 3:29
Binning JM, Leung DW, Amarasinghe GK (2012) Aptamers in virology: recent advances and challenges. Front Microbiol 3:29
Biroccio A, Hamm J, Incitti I et al (2002) Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J Virol 76:3688–3696
Boiziau C, Dausse E, Yurchenko L et al (1999) DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes. J Biol Chem 274:12730–12737
Boucard D, Toulmé JJ, Di Primo C (2006) Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures. Biochemistry 45:1518–1524
Bunka DH, Stockley PG (2006) Aptamers come of age—at last. Nat Rev Microbiol 4:588–596
Chen Y, Nakamoto K, Niwa O et al (2012) On-chip synthesis of RNA aptamer microarrays for multiplexed protein biosensing with SPR imaging measurements. Langmuir 28:8281–8285
Choi SK, Lee C, Lee KS et al (2011) DNA aptamers against the receptor binding region of hemagglutinin prevent avian influenza viral infection. Mol Cells 32:527–533
Collett JR, Cho EJ, Ellington AD (2005) Production and processing of aptamer microarrays. Methods 37:4–15
Collin D, van Heijenoort C, Boiziau C et al (2000) NMR characterization of a kissing complex formed between the TAR RNA element of HIV-1 and a DNA aptamer. Nucleic Acids Res 28:3386–3391
Comolli LR, Pelton JG, Tinoco I Jr (1998) Mapping of a protein-RNA kissing hairpin interface: Rom and Tar-Tar*. Nucleic Acids Res 26:4688–4695
Cox JC, Ellington AD (2001) Automated selection of anti-protein aptamers. Bioorg Med Chem 9:2525–2531
Cui ZQ, Ren Q, Wei HP et al (2011) Quantum dot-aptamer nanoprobes for recognizing and labeling influenza A virus particles. Nanoscale 3:2454–2457
Cullen DC, Brown RG, Lowe CR (1987) Detection of immuno-complex formation via surface plasmon resonance on gold-coated diffraction gratings. Biosensors 3:211–225
Da Rocha GS, Dausse E, Toulmé JJ (2004) Determinants of apical loop-internal loop RNA-RNA interactions involving the HCV IRES. Biochem Biophys Res Commun 322:820–826
Darfeuille F, Cazenave C, Gryaznov S et al (2001) RNA and N3′-->P5′ kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1. Nucleosides Nucleotides Nucleic Acids 20:441–449
Darfeuille F, Arzumanov A, Gait MJ et al (2002a) 2′-O-methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry 41:12186–12192
Darfeuille F, Sekkai D, Dausse E et al (2002b) Driving in vitro selection of anti-HIV-1 TAR aptamers by magnesium concentration and temperature. Comb Chem High Throughput Screen 5:313–525
Darfeuille F, Hansen JB, Orum H, Di Primo C, Toulmé JJ (2004) LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res 2004(2):3101–3107
Darfeuille F, Reigadas S, Hansen JB et al (2006) Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Biochemistry 45:12076–12082
Dausse E, Cazenave C, Rayner B et al (2005) In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins. Methods Mol Biol 288:391–410
Dausse E, Da Rocha GS, Toulmé JJ (2009) Aptamers: a new class of oligonucleotides in the drug discovery pipeline? Curr Opin Pharmacol 9:602–607
Dausse E, Taouji S, Evadé L et al (2011) HAPIscreen, a method for high-throughput aptamer identification. J Nanobiotechnology 9:25
Davis DR, Seth PP (2011) Therapeutic targeting of HCV internal ribosomal entry site RNA. Antivir Chem Chemother 21:117–128
Demeulemeester J, Tintori C, Botta M et al (2012) Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors. J Biomol Screen 17:618–628
Di Primo C, Rudloff I, Reigadas S et al (2007) Systematic screening of LNA/2′-O-methyl chimeric derivatives of a TAR RNA aptamer. FEBS Lett 581:771–774
Diviney S, Tuplin A, Struthers M et al (2008) A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. J Virol 82:9008–9022
Ducongé F, Toulmé JJ (1999) In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. RNA 5:1605–1614
Ducongé F, Di Primo C, Toulmé JJ (2000) Is a closing “GA pair” a rule for stable loop-loop RNA complexes? J Biol Chem 275:21287–21294
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822
Eulberg D, Buchner K, Maasch C et al (2005) Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res 33:e45
Fagerstam LG, Frostell A, Karlsson R et al (1990) Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recognit 3:208–214
Finlay BB, McFadden G (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124:767–782
Friebe P, Bartenschlager R (2002) Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 76:5326–5538
Fu W, Gorelick RJ, Rein A (1994) Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol 68:5013–5508
Gold L, Ayers D, Bertino J et al (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5:e15004
Gopinath SC, Kawasaki K, Kumar PK (2005) Selection of RNA-aptamer against human influenza B virus. Nucleic Acids Symp Ser (Oxf) (49):85–86
Gopinath SC, Sakamaki Y, Kawasaki K et al (2006) An efficient RNA aptamer against human influenza B virus hemagglutinin. J Biochem (Tokyo) 139:837–846
Gordon CG, Mackey JL, Jewett JC et al (2012) Reactivity of biarylazacyclooctynones in copper-free click chemistry. J Am Chem Soc 134:9199–9208
Gregorian RS Jr, Crothers DM (1995) Determinants of RNA hairpin loop-loop complex stability. J Mol Biol 248:968–984
Guedon P, Livache T, Martin F et al (2000) Characterization and optimization of a real-time, parallel, label-free, polypyrrole-based DNA sensor by surface plasmon resonance imaging. Anal Chem 72:6003–6009
Heiny AT, Miotto O, Srinivasan KN et al (2007) Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2:e1190
Henn C, Boettcher S, Steinbach A et al (2012) Catalytic enzyme activity on a biosensor chip: combination of surface plasmon resonance and mass spectrometry. Anal Biochem 428:28–30
James W (2007) Aptamers in the virologists’ toolkit. J Gen Virol 88:351–364
Jayaprakash KN, Peng CG, Butler D et al (2010) Non-nucleoside building blocks for copper-assisted and copper-free click chemistry for the efficient synthesis of RNA conjugates. Org Lett 12:5410–5413
Jeon SH, Kayhan B, Ben-Yedidia T et al (2004) A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem 279:48410–48419
Karn J (1999) Tackling Tat. J Mol Biol 293:235–254
Kikuchi K, Umehara T, Fukuda K et al (2003) RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region. J Biochem (Tokyo) 133:263–270
Kikuchi K, Umehara T, Fukuda K et al (2005) A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Res 33:683–692
Kikuchi K, Umehara T, Nishikawa F et al (2009) Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Biochem Biophys Res Commun 386:118–123
Kolb G, Reigadas S, Castanotto D et al (2006) Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication. RNA Biol 3:150–156
Kota S, Coito C, Mousseau G et al (2009) Peptide inhibitors of hepatitis C virus core oligomerization and virus production. J Gen Virol 90:1319–1328
Krone JR, Nelson RW, Dogruel D et al (1997) BIA/MS: interfacing biomolecular interaction analysis with mass spectrometry. Anal Biochem 244:124–132
Kupakuwana GV, Crill JE 2nd, McPike MP et al (2011) Acyclic identification of aptamers for human alpha-thrombin using over-represented libraries and deep sequencing. PLoS One 6:e19395
Lautner G, Balogh Z, Bardoczy V et al (2010) Aptamer-based biochips for label-free detection of plant virus coat proteins by SPR imaging. Analyst 135:918–926
Lebars I, Legrand P, Aimé A et al (2008) Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance. Nucleic Acids Res 36:7146–7156
Lima WF, Crooke ST (1997) Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry 36:390–398
Lopez F, Pichereaux C, Burlet-Schiltz O et al (2003) Improved sensitivity of biomolecular interaction analysis mass spectrometry for the identification of interacting molecules. Proteomics 3:402–412
Mairal T, Cengiz Ozalp V, Lozano Sanchez P et al (2007) Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 390:989–1007
Marton S, Berzal-Herranz B, Garmendia E et al (2012) Anti-HCV RNA aptamers targeting the genomic cis-acting replication element. Pharmaceuticals 5:49–60
Mascini M, Palchetti I, Tombelli S (2012) Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. Angew Chem Int Ed Engl 51:1316–1332
Mayer G (2009) The chemical biology of aptamers. Angew Chem Int Ed Engl 48:2672–2689
Misono TS, Kumar PK (2005) Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal Biochem 342:312–317
Muriaux D, De Rocquigny H, Roques BP et al (1996) NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J Biol Chem 271:33686–33692
Nair TM, Myszka DG, Davis DR (2000) Surface plasmon resonance kinetic studies of the HIV TAR RNA kissing hairpin complex and its stabilization by 2-thiouridine modification. Nucleic Acids Res 28:1935–1940
Negri P, Kage A, Nitsche A et al (2011) Detection of viral nucleoprotein binding to anti-influenza aptamers via SERS. Chem Commun (Camb) 47:8635–8637
Negri P, Chen G, Kage A et al (2012) Direct optical detection of viral nucleoprotein binding to an anti-influenza aptamer. Anal Chem 84:5501–5508
Nitsche A, Kurth A, Dunkhorst A et al (2007) One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX. BMC Biotechnol 7:48
Park SY, Kim S, Yoon H et al (2011) Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus. Nucleic Acid Ther 21:395–402
Pileur F, Andreola ML, Dausse E, Michel J, Moreau S, Yamada H, Gaidamakov SA, Crouch RJ, Toulmé JJ, Cazenave C (2003) Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res 31:5776–5788
Pinheiro VB, Taylor AI, Cozens C et al (2012) Synthetic genetic polymers capable of heredity and evolution. Science 336:341–344
Remy-Martin F, El Osta M, Lucchi G et al (2012) Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA-MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma. Anal Bioanal Chem 404:423–432
Rich RL, Myszka DG (2011) Survey of the 2009 commercial optical biosensor literature. J Mol Recognit 24:892–914
Robertson DL, Joyce GF (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344:467–468
Roh S, Chung T, Lee B (2012) Overview of the characteristics of micro- and nano-structured surface plasmon resonance sensors. Sensors 11:1565–1588
Romero-Lopez C, Diaz-Gonzalez R, Barroso-delJesus A et al (2009) Inhibition of hepatitis C virus replication and internal ribosome entry site-dependent translation by an RNA molecule. J Gen Virol 90:1659–1669
Sehr P, Pawlita M, Lewis J (2007) Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/E6AP interaction inhibitors using AlphaScreen. J Biomol Screen 12:560–567
Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX–a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24:381–403
Sundaram P, Kurniawan H, Byrne ME et al (2012) Therapeutic RNA aptamers in clinical trials. Eur J Pharm Sci 48:259–271
Taouji S, Dahan S, Bosse R et al (2009) Current screens based on the AlphaScreen technology for deciphering cell signalling pathways. Curr Genomics 10:93–101
Tintori C, Demeulemeester J, Franchi L et al (2012) Discovery of small molecule HIV-1 integrase dimerization inhibitors. Bioorg Med Chem Lett 22:3109–3114
Tombelli S, Minunni M, Luzi E et al (2005) Aptamer-based biosensors for the detection of HIV-1 Tat protein. Bioelectrochemistry 67:135–141
Toulmé J-J, Di Primo C, Moreau S (2001) Modulation of RNA function by oligonucleotides recognizing RNA structure. Prog Nucleic Acid Res Mol Biol 69:1–46
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
Tuerk C, MacDougal S, Gold L (1992) RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 89:6988–6992
Ullman EF, Kirakossian H, Singh S et al (1994) Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci USA 91:5426–5430
Upert G, Di Giorgio A, Upadhyay A et al (2012) Inhibition of HIV replication by cyclic and hairpin PNAs targeting the HIV-1 TAR RNA loop. J Nucleic Acids 2012:591025
Van Melckebeke H, Devany M, Di Primo C et al (2008) Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex. Proc Natl Acad Sci USA 105:9210–9215
Wang Z, Wilkop T, Xu D et al (2007) Surface plasmon resonance imaging for affinity analysis of aptamer-protein interactions with PDMS microfluidic chips. Anal Bioanal Chem 389:819–825
Wang RE, Wu H, Niu Y et al (2011) Improving the stability of aptamers by chemical modification. Curr Med Chem 18:4126–4138
Watrin M, Von Pelchrzim F, Dausse E et al (2009) In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1. Biochemistry 48:6278–6284
Zhou J, Rossi JJ (2011) Cell-specific aptamer-mediated targeted drug delivery. Oligonucleotides 21:1–10
Zhou J, Bobbin ML, Burnett JC et al (2012) Current progress of RNA aptamer-based therapeutics. Front Genet 3:234
Zimmermann B, Gesell T, Chen D et al (2010) Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX. PLoS One 5:e9169
Acknowledgments
We thank Dr Sonia Da Rocha, Mrs Laetitia Evadé, and Ms Emilie Daguerre (Bordeaux) for sharing unpublished results.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Toulmé, JJ., Primo, C.D., Dausse, E., Desmecht, D., Cornet, F., Azéma, L. (2013). Aptamers: Analytical Tools for Viral Components. In: Erdmann, V., Barciszewski, J. (eds) DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. RNA Technologies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36853-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-36853-0_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36852-3
Online ISBN: 978-3-642-36853-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)